Atrial fibrillation (AF) is the most common rhythm disorder. The consequences of undiagnosed AF are an increased risk of developing of heart failure and thromboembolic complications. The article is devoted to study of the possibility of using the medical device MyDiagnostick 1001R® in clinical practice for patients with the risk of AF development for early stage diagnosis. Methods. A group of subjects included 30 patients who did not have a history of AF, but who had the risk factors for its development — arterial hypertension, diabetes, obesity, ischemic heart disease (IHD). The average age of participants was 65.9 ± 12.1 years. A questionnaire containing 16 questions was developed to identify the risk factors of AF development. Results. From 30 participants 80% had arterial hypertension, 43.3% diabetes, 3.3% were obese, 50% suffered from IHD, 16.6% had stroke in anamnesis and 23.3% were smokers. All patients had a combination of risk factors. As a result, with the help of MyDiagnostick 1001R® 26.7% (8 patients) of the group was discovered to have AF episodes. For all participants recommendations for further examination and treatment were given. Conclusions. MyDiagnostick 1001R® is a simple device that does not require additional equipment, and allows to identify previously undiagnosed AF within 24 hours for subsequent diagnosis. It allows us to recommend this device for screening of patients with AF risk factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.